Bone turnover markers for osteoporotic status assessment? A systematic review of their diagnosis value at baseline in osteoporosis

详细信息	查看全文 | 推荐本文 |

• 作者：Emmanuel Biver^a ; ^{ebiver@yahoo.fr} ; Florence Chopin^b ; Guillaume Coiffier^c ; Thomas Funck Brentano^d ; Bé ; atrice Bouvard^e ; Patrick Garnero^f ; Bernard Cortet^a
• 关键词：Osteoporosis ; Bone mineral density ; Bone turnover markers ; Vertebral fractures
• 刊名：Joint Bone Spine
• 出版年：2012
• 期刊代码：138_1297319x
• 类别：med
• 出版时间：January, 2012
• 卷：79
• 期：1
• 页码：20-25
• 文件大小：706 K

摘要

Objective

Osteoporosis diagnosis is based on bone mineral density (BMD) but bone remodeling is also a crucial issue. It can be assessed by bone turnover markers (BTMs). Their interest for the positive and etiological diagnosis of osteoporosis at baseline, and their predictive value for past asymptomatic vertebral fractures, were evaluated by a systematic review of the literature.

Methods

Medline database was searched to identify all published reports analyzing BTMs and BMD or fractures. We conducted meta-analyses on BTMs levels according to osteoporotic status using random effects models.

Results

Moderate and negative correlations were found, mainly in postmenopausal women, between BTMs and BMD, especially with bone alkaline phosphatase (bone ALP), osteocalcin, serum C-terminal and urine N-terminal crosslinking telopeptides of type I collagen (sCTX and uNTX). Bone ALP and sCTX levels are higher in osteoporotic patients compared to controls. High levels of bone ALP in primary hyperparathyroidism and low levels of osteocalcin in endogenous hypercorticism are the most relevant data reported in endocrine diseases associated with osteoporosis. High levels of BTMs, especially osteocalcin, bone ALP or sCTX, may be associated with prevalent vertebral fractures.

Conclusion

The diagnosis value of BTMs at baseline in osteoporosis is very low. The interest of BTMs for the etiological diagnostic of secondary osteoporosis has not been demonstrated. Data are lacking to address the interest of BTMs assessment to screen for vertebral fractures in asymptomatic patients with high risk factors of fractures.